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Relation between coronary risk and coronary
mortality in women of the Renfrew and Paisley
survey: comparison with men
Most epidemiological and intervention studies in
patients with coronary artery disease have focused
on men, the assumption being that such data can be
extrapolated to women. However, there is little
evidence to support this belief.
We have completed a fifteen-year follow-up of
15 399 adults, including 8262 women, who lived in
Renfrew and Paisley and were aged 45-64 years
when screened between 1972 and 1976. We
identified 490 deaths from coronary heart disease
(CHD) in women and 878 in men. Women were
more likely to have high cholesterol, to be obese, and
to come from lower social classes than men, but they
smoked less and had similar blood pressures. The
relative risk&mdash;top to bottom quintile (95% Cl)&mdash;of
cholesterol for coronary death after adjustment for all
other risk markers was slightly greater in women
(1&middot;77 [1&middot;45, 2&middot;16]) than in men (1&middot;56 [1&middot;32, 1&middot;85]),
but absolute and attributable risk were lower. Thus,
women in the top quintile for cholesterol had lower
coronary mortality (6&middot;1 deaths per thousand patient
years) than men in the bottom quintile (6&middot;8 deaths
per thousand patient years). Moreover, it was
estimated that there would have been only 103
(21 %) fewer CH D deaths in women, yet 211 (24%)
fewer in men, if mortality had been the same for
women and men in the lowest quintiles of
cholesterol. Trends showing similar relative risks in
these women, but lower absolute and attributable
risks than in men, were present for smoking, diastolic
blood pressure, and social class. There was no
relation between obesity and coronary death after
adjustment for other risks.
Our results suggest that some other factors protect
women against CHD. The potential for women to
reduce their risk of CH D by changes in lifestyle may
be less than for men.
Introduction
Rates of coronary heart disease (CHD) increase with age
in both sexes but are higher in men than in women.’ Most
population studies and intervention trials have focused on
the relation between coronary risk and coronary disease,
together with the effects of reducing cholesterol, in men.
However, recommendations for prevention of coronary
disease do not distinguish between men and women on the
grounds that what is good for men is likely to benefit women.
This approach could only be justified if the absolute and
attributable risks of CHD were similar, and if preventive
measures were effective in both sexes. To examine risk
further, we have analysed the relation of coronary heart
disease with plasma cholesterol, cigarette smoking, diastolic
blood pressure, body mass index, and social class in a general
population of 15 399 middle-aged adults, including 8262
women, who were screened in Renfrew and Paisley between
1972 and 1976 and then followed up until the end of 1989.
Methods
The Renfrew and Paisley survey is a longitudinal health study of
15 399 subjects, including 8262 women, who were aged 45 to 64
years when first examined between 1972 and 1976. The subjects
were taken as representative of an urban population in the west of
Scotland. The survey was preceded by a census and each man and
woman between the ages of 45 and 64 years was visited and given an
invitation to attend; 79% of eligible subjects in Renfrew and 78% of
those in Paisley did so. During the first two years offollow-up, those
not attending had higher mortality than those who did attend.
Thereafter, mortality rates were similar in attenders and non-
attenders.
Fig 1-Distribution of plasma cholesterol among 8262
women and 7137 men aged 45-64 years.
Smoking habits were recorded by a standard questionnaire and
measurements were made of height and weight (to give body mass
index in kg/m2), blood pressure (London School of Hygiene
sphygmomanometer, diastolic phase V), and non-fasting plasma
cholesterol. Social class was determined by occupation, except for
housewives and retired women whose husbands’ or fathers’
occupations were used instead in classification.
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Age years
Fig 2-Mean (99% CI) plasma cholesterol in women and men.
Records kept with the Registrar General in Scotland ensured
notification of a subject’s death, provided it took place in the UK,
together with the cause of death according to the 9th revision of the
International Classification of Diseases (ICD) codes.3 Although
uncertainties about cause of death taken from the death certificate
have been noted,’ we had previously assessed the methods of the
Registrar General in a study of hypertensive patients.’ Notification
from the Registrar General was virtually complete and coding
comparisons of causes of death by the Registrar and by independent
physicians yielded no important discrepancies. Full details of our
methods have been published elsewhere.6
Our analysis concerns the relation between markers of coronary
risk and coronary disease in women, and a comparison with
better-known fmdings in men. For this study, we have taken
15-year mortality data based on 490 CHD deaths in women and 878
CHD deaths in men (ICD codes 410-414). CHD mortality rates
were calculated as deaths per 1000 patient years of follow-up, and
then adjusted for all variables (age, smoking, cholesterol, diastolic
blood pressure, body mass index, and social class), except for the
variable of interest, before the data were arranged in quintiles. The
quintile points for cholesterol were 5-5, 6,1, 66, and 7 -2 mmol/l in
women, and 5-0, 56, 60, and 6-6 mmol/1 in men. Corresponding
values for diastolic blood pressure were 74,80,87, and 95 mm Hg in
women and 74, 81, 88, and 96 mm Hg in men. Quintile points for
body mass index were 222, 24-2, 262, and 28.9 kg/m2 in women,
and 23 0,24-9, 26-6, and 28.5 5kg/m2 in men. CHD mortality was
also assessed by smoking category (zero, 1-14, =15 cigarettes per
day, ex-smoker) and by social class (1 and 2, 3 non-manual, 3
manual, and 4 and 5). We applied a proportional hazards model to
evaluate trends in mortality across each risk distribution after
adjustment for other risk markers.
Results
Prevalence of risk markers in women
Fig 1 shows the distribution of plasma cholesterol in
women and men. Mean (SD) values were higher in women
(6-43 [1.09] mmol/1) than in men (5-87 [0.96] mmol/1). The
proportion of women with cholesterol greater than 52, 6-5,
and 7-8 mmol/1 was 89-0%, 47-8%, and 11-2%,
respectively; corresponding values for men were 77-6%,
26-3%, and 3-3%, respectively. The difference between the
sexes was a result of higher cholesterol concentrations in
older women than in older men (fig 2).
Women were less likely than men to smoke or to be heavy
smokers (table I). Both average diastolic blood pressure and
the proportion of subjects with a diastolic pressure greater
than 90 mm Hg were similar in men and women. More men
than women were overweight (body mass index 25-29
kgfm2) but a higher proportion of women were obese (body
mass index > 29 kg/m2) .7 Although husbands and wives
shared social class, among those who were unmarried a
higher proportion of women belonged to social classes 4 and
5 (table i).
TABLE I-DISTRIBUTION OF RISK MARKERS AMONG WOMEN
AND MEN
DBP=diastolic blood pressure, BMl body mass Index.
*<18 5 is underweight, 18 5-25 0 ideal; 25.0--29.0 overweight, :&ccedil; 29.0 obese 7
Coronary risk and mortality
There were 490 CHD deaths in women and 878 CHD
deaths in men. Although menopausal status was not known
for individual patients, only one female coronary death
occurred before age 52 (the average age of menopause in the
UK). Thus, most mortalities among women in our study
were postmenopausal.
15-year CHD mortality by baseline plasma cholesterol
and other coronary risk markers is shown in figs 3 and 4.
Plasma cholesterol, cigarette smoking, diastolic blood
pressure, and low social class were positively and
independently associated with CHD mortality in both sexes,
whereas there was no relation between body mass index and
CHD after adjustment for other risk markers.
The relative risk of coronary death (top to bottom
quintile) was similar in both sexes (table II). In women, the
absolute risk was less in that, for a given risk factor, women
with high individual risks generally had a lower coronary
mortality than men with low risks. Fig 3 shows that women
with cholesterol concentrations above 72 mmol/1 had a
masma cnoiesteroi (mmol/l)
Fig 3-Adjusted CHD mortality in deaths per 1000 patient
years for men and women by quintile of plasma cholesterol.
There were 490 CHD deaths in women with a relative risk of 1 77
(p<0001). Corresponding figures for men were 878 CHD deaths,
relative risk 1 56 (p<0 001).
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Fig 4-Adjusted CHD mortality in deaths per thousand patient
years for both sexes by cigarette smoking, diastolic
pressure, social class, and body mass index.
p<0.001 for smoking, diastolic pressure, and social class No
significant influence on CHD mortality was found for body mass index.
For each of the four analyses risks were greater in men
lower risk of CHD than men with cholesterol values below
5-0 mmol/1. Similar trends were present for blood pressure,
smoking, and social class (fig 4).
The best estimate of the number of CHD deaths
attributable to any given risk marker is known as attributable
risk-ie, the number of CHD deaths that would not have
taken place if the levels of that risk marker had been in the
lowest category of risk. All attributable risks in our
population were less in women than in men (table II). More
lives could have been saved if the whole population had not
smoked than by any other single intervention, assuming that
these other measures would be completely effective in
reversing risk (table n). Calculation of attributable risk for
cholesterol indicated that there would have been 103 (21 %)
fewer CHD deaths in women and 211 (24%) fewer CHD
deaths in men if the mortality of the whole group had been
the same as that among women and men whose cholesterol
concentrations were in the lowest quintile. Attributable risks
for diastolic blood pressure and low social class are also
shown in table 11.
TABLE II-RELATIVE AND ATTRIBUTABLE RISK OF CORONARY
DEATH IN MEN AND WOMEN
NS, not-significant.
Relative risk for cholesterol, diastolic pressure, and body mass index is the ratio of the
top to bottom quintile for each risk marker, for smokers It is the ratio of the rate for
current smokers who smoke 15 or more cigarettes per day to the rate of lifelong
non-smokers, for social class It is the rate for classes 4 and 5 combined to classes 1
and 2 combined
Fig 5-Age-specific CHD mortality (95% CI) adjusted for all
other risk markers.
p < 0 001 for differences between sexes at all ages
The possibility that absolute risk was lower in women
because women are protected by female sex hormones was
investigated by calculating age-specific coronary death rates
in both sexes after adjustment for all other risks (fig 5). Our
results are consistent with this hypothesis and show that
women have a substantially lower coronary mortality than
men at every age studied. Although the gradient of risk
tended to steepen in older women, postmenopausal women
aged 60-64 years still had the same risk of coronary death as
men 5-10 years younger and only half the coronary
mortality of men aged 60-64 years.
Discussion
A recurring feature in most reviews about coronary
prevention is the lack of data on women.2 Few longitudinal
studies on cholesterol8-12 and only three of the major
cholesterol-lowering drug trials13-15 included women.
The Renfrew and Paisley survey is one of very few
longitudinal health surveys in the UK to provide mortality
data for women. The Scottish Heart Health Study16,17 will
give results for women in Scotland, but the screening survey
has only recently been completed and it may be some time
before mortality data are available. A case-control study of
coronary risk factors among UK women has been
published, but this did not include measurement of serum
cholesterol.18 One further advantage of the Renfrew and
Paisley survey is the large number of coronary deaths in
women (490), which is greater than the combined total of
female coronary deaths (384) published in five other large
surveys. 8-12
The main limitations of our study are the lack of
morbidity data and the absence of repeated measurements of
risk markers during follow-up.19 Death and its cause were
certified by general practitioners but were not verified by
independent observers. This method has disadvantages but
is unlikely to introduce systematic bias.19 Our approach has
also been used by the Registrar General in his analysis of
national statistics on CHD. Moreover, it is unlikely that
cancer deaths will have been wrongly classified because the
existence of a cancer registry in the west of Scotland allowed
for independent confirmation.
Renfrew and Paisley have an especially high incidence of
coronary disease. Our results indicate that the distribution of
risk markers is different in men and women (table I, figs 1
and 2); that "dose responses" exist for cholesterol, cigarette
smoking, diastolic blood pressure, and social class in both
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sexes (figs 3 and 4); and that relative risks are similar in men
and women (table II), although absolute and attributable
risk are very much lower in women (table II, figs 3 and 4),
The reasons underlying the lower incidence of CHD in
women remain unclear. Women may have a lower
frequency of risk markers than men. Our survey suggests
that they smoke less and have similar blood pressure, but
have higher cholesterol and are more likely to be obese and
of lower social class. However, the lower level of smoking
among women cannot be the whole explanation for the
difference in death rates because non-smoking women have
only half the coronary mortality of non-smoking men (fig 4).
Similar findings have been reported from other centres. 8
The social class differences between men and women are
difficult to interpret because housewives and retired women
assume their husbands’ or fathers’ social class. The large
proportion of women who belong to social classes 4 and 5 is,
however, likely to reflect unmarried women employed in
textile, clothing, clerical, and service industries.
Women may tolerate risks better than men. We found
that, in women, any given level of risk marker was associated
with lower CHD rates than men. This protection might be
conferred by female sex hormones. Our data are consistent
with this explanation: even in women who were 60-64 years
initially, CHD rates were substantially lower than in men of
similar age, suggesting that natural oestrogen may protect
for many years beyond the menopause (fig 5).
High-density lipoprotein (HDL) cholesterol was not
measured routinely in our survey, although data from other
centres20 confirm that HDL is higher in women than in men
and suggest that this difference may explain the lower female
coronary rate. The relation between gender, lipoproteins,
and coronary risk is complex, and a small sex difference in
HDL concentration is unlikely to be entirely responsible for
the large differences in CHD mortality that exist in Renfrew
and Paisley. Non-contraceptive hormones in
postmenopausal women may also confer protection against
CHD,20 but the frequency of hormone replacement therapy
in Renfrew and Paisley was not recorded, although it is likely
to have been low in the early 1970s. Triglyceride may have a
more important influence on CHD risk in women than in
men,21 but it is unlikely that this could account for the sex
differences observed in our study.
Several areas of uncertainty remain. Despite the lower
incidence of CHD among women generally, diabetic
women may have the same absolute risk of developing CHD
as diabetic men.8 Furthermore, women might be more likely
than men to have angina or painless myocardial infarction as
their initial presentation8 and there are no sex differences in
prognosis after myocardial infarction. 22
How should women be advised? They should be urged
not to smoke and to stop if they do smoke.23 The evidence
that control of blood pressure reduces the risk of myocardial
infarction is weaker for women than it is for men,24 but
treatment of hypertension should be recommended because
it is of proven value in the reduction of stroke in both sexes.25
Regular physical exercise may protect against CHD,
although such advice is derived from studies in men.26
Although body mass index was not an independent risk
factor for CHD in our study, advice that obese women
should lose weight is justified on general health grounds, and
because weight loss is likely to facilitate management of
hypertension and hyperlipidaemia. Indices of central
obesity, such as waist-to-hip ratio and subscapular skin fold,
may have greater predictive power than body mass index for
CHD,2’ but neither were measured in Renfrew and Paisley.
Only three lipid-lowering studies have included
women.13-15 The first was a study of patients with pre-
existing heart disease13 and the second was of patients with
familial hypercholesterolaemia.14 Both studies suggested a
benefit to women, but neither addressed the issue of primary
prevention of CHD in women with moderately raised
increases of their serum cholesterol. A third study was a
secondary prevention trial in which the effects of
cholestyramine and placebo on atheroma progression were
compared; its results were inconclusive.
Definitive guidelines for the treatment of
hypercholesterolaemia in women must await the results of
further clinical trials. These will not be available for several
years and until then any recommendations for women will
have to be judged from estimates of risk rather than of
benefit from reduction of risk. If absolute or attributable risk
is the criterion on which such judgments should be based,
the results of our survey suggest that for primary prevention
of CHD the threshold for introduction of cholesterol-
lowering drug therapy should be higher in women than in
men.
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Renal biopsies were done perioperatively in
18 children receiving liver grafts. All specimens
showed glomerulonephritis, which was mesangial-
proliferative in 15 and mesangio-capillary in 3. Of the
16 children who were alive four or more months after
transplantation, only 1 showed progressive
deterioration of renal function; 1 other had a
subnormal but static glomerular filtration rate. In all 6
children who had proteinuria before operation, the
urine became normal.
The association of nephropathy with chronic liver disease
has been thought infrequent. Now that transplantation has
become an accepted treatment for end-stage liver disease the
question assumes greater importance: glomerulonephritis
might complicate the postoperative course and worsen the
long-term outcome. In 5 children with liver disease due to
alpha-1-antitrypsin deficiency, evidence of renal
dysfunction led us to do renal biopsies, and in every case the
kidney showed abnormalities. We therefore investigated the
association systematically in a further 13 children receiving
first liver grafts.
The study was approved by an ethics committee and no parents
withheld consent. This report includes the original 5 children with
alpha-1-antitrypsin deficiency. The 13 children in the prospective
series had liver disease of various causation (see table), and renal
biopsy was done during liver grafting. These patients were selected
consecutively unless at operation the procedure was judged
dangerous (there were no complications). The specimens were
divided and processed for routine histological examination, frozen-
section immunofluorescence, and electronmicroscopy.
All 18 biopsy specimens showed abnormalities (see table):
15 children had a mesangialproliferative glomerulonephritis
(immune staining positive for IgA in 8 and for IgM in 1;
diffuse immune complex staining in 1). 3 children had
mesangio-capillary glomerulonephritis. Tubular changes
(mild necrosis) were seen in only 1 patient, who had
potassium wasting disease.
16 children survived to follow-up at 4-34 months (mean 5
months). The urine became normal in all 7 who had shown
proteinuria or haematuria before operation (proteinuria 3,
proteinuria/haematuria 3, haematuria 1). Only 1 child
showed clear long-term deterioration in renal function
postoperatively: she had mesangio-capillary
glomerulonephritis, and her glomerular filtration rate
declined from normal to 25 % in the year after
transplantation. Another child, who had
mesangialproliferative glomerulonephritis and a scarred
right kidney, had a subnormal (25%) but stable glomerular
filtration rate.
Blood-pressures tended to rise postoperatively (table),
and 7 children had seizures or encephalopathy within the
PATIENT DETAILS
*Patients studied before prospective series. MPG = mesangialproliferative glomerulonephritis MCGN = mesangio-capillary glomerulonephritis. N/A= not applicable
